Brief: Theravance Biopharma Announces Tender Offer For Up To $95 Million Of Its Ordinary Shares
28/09/2022 11:08
Sept 28 (Reuters) - Theravance Biopharma Inc TBPH.O :
* THERAVANCE BIOPHARMA INC - THERAVANCE BIOPHARMA ANNOUNCES
TENDER
OFFER FOR UP TO $95 MILLION OF ITS ORDINARY SHARES
* THERAVANCE BIOPHARMA INC - PAR VALUE $0.00001 PER SHARE
* THERAVANCE BIOPHARMA INC - PURCHASE PRICE NOT GREATER THAN
$10.50 NOR LESS THAN $9.75 PER SHARE
Source text for Eikon: ID:nPn6Z0sNka
Further company coverage: TBPH.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Theravance Biopharma
See all newsIreland's Theravance Biopharma Q1 revenue beats estimates on YUPELRI growth
Ireland's Theravance Biopharma Q4 revenue misses expectations
Corrected: BRIEF-Theravance Biopharma Q4 Operating Income USD 20.012 Million
U.S. STOCKS ON THE MOVE-Versant Media Group, Lithium miners, Expedia Group
U.S. STOCKS ON THE MOVE-Expedia Group, Blue Owl Capital, Enphase Energy